An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
2022-11-21
عنوان الدراسة
An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
داعم الدراسة
Global Blood Therapeutics (GBT)
دواء الدراسة
Inclacumab
رقم بروتوكول الدراسة
GBT2104-133
حالة الدراسة
Ongoing
موقع الدراسة
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。